B24Dolutegravir-based regimen is associated with metabolic syndrome components among persons with HIV in sub-Saharan AfricaE-posterMetabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy)
B24Does weight gain on Bictegravir/Emtricitabine/Tenofovir Alafenamide (B) lead to metabolic syndrome?E-posterMetabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy)
D2Does onsite HIV self-testing enhance linkage to care? A case study of HIVST Challenge Fund Project in KenyaE-posterImpact evaluation of differentiated service delivery
D82Do childhood and adolescence sexual violence experiences relate to HIV testing and PrEP uptake in young adulthood among MSM of color living in an urban area of the United States?On-demand oral abstract sessionGay, bisexual, and other men who have sex with men
D76Distinct forms of population mobility are differentially associated with objectively measured antiretroviral treatment (ART) adherenceE-posterMigration and HIV
C55Disseminated effects of the initial training and subsequent booster sessions components of the HIV Prevention Trials Network 037 peer-driven intervention on HIV injection risk behavior in people who inject drugsE-posterPrevention in people who inject drugs
D33Disparate HIV viral load suppression rates between rural and urban populations of Uganda from July 2019 through June 2020E-posterScale up of viral load monitoring
D110Discrimination response, an alternative forum to resolve grievanceE-posterInterventions to reduce stigma and discrimination
C32Discreetness and pain avoidance as central drivers of preferred characteristics in an HIV prevention implant among women in Zimbabwe and South AfricaE-posterNovel delivery systems (e.g., rings, implants, transdermal systems)
D47Discontinuation and inadequate adherence to pre-exposure prophylaxis of HIV: a systematic review and meta-analysisE-posterMonitoring and evaluation of prevention
661 - 670 of 870 items